NCT00316719 Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients Status COMPLETED Phase PHASE3
NCT00307489 Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil Status COMPLETED Phase PHASE2
NCT00307242 Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT00298363 Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease. Status COMPLETED Phase PHASE2
NCT00291616 Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT00277576 Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection Status COMPLETED Phase PHASE1
NCT00275938 Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B Status COMPLETED Phase PHASE2/PHASE3
NCT00263614 Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. Status COMPLETED Phase N/A
NCT00226447 Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients Status COMPLETED Phase PHASE2
NCT00226382 Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment Status COMPLETED Phase PHASE4
NCT00221286 Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients Status TERMINATED Phase PHASE3
NCT00199732 Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a Status COMPLETED Phase N/A
NCT00142298 Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies Status COMPLETED Phase PHASE3
NCT00140725 Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) Status COMPLETED Phase PHASE3
NCT00132652 Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B Status COMPLETED Phase PHASE3
NCT00131742 Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B Status COMPLETED Phase PHASE3
NCT00117676 A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B Status COMPLETED Phase PHASE3
NCT00117533 Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta Status UNKNOWN Phase PHASE4